Fund Companies Rights Offerings Managed Distributions Leveraged Funds IPOs Asset Classes CEF Advisors

My Fund Comparison
Initilizing list...

H&Q Healthcare Investors  as of 05/21/2013

NYSE / HQH Asset Class:  Sector Equity Funds 1 YR Lipper Avg:  26.35%

Growth of $10K

Avg Annual Total Return %
  10 YR 5 YR 1 YR YTD
Market Return 12.31% 16.48% 49.72% 34.16%
Lipper Pct. Rank 25 7 9 4
NAV Return 10.72% 13.07% 40.17% 27.62%
Lipper Pct. Rank 58 20 4 3
Premium/Discount History

Premium/Discount
10 YR Avg 5 YR Avg YTD Avg
-8.725% -12.365% -3.400%

NAV $23.10 Market Price $22.79
Net Change $0.18 Market Change $0.08
Premium/Discount -1.34%
1 YR NAV Return 40.173%
1 YR NAV Rank 4
12-Mo Yield as of 4/30/2013 Yield Def
Income Only Yield 0.00%
Distribution Yield (Market) 6.69%
Managed Distribution Plan 
Most Recent Income Dividend $0.370
Ex-Div Date 2/27/2013
Most Recent Cap Gain Dividend $0.380
Ex-Div Date 11/19/2012
Dividend Frequency Quarterly
YTD Dividends $0.370
YTD Capital Gains --
Inception Date 4/23/1987
Fund Advisor Tekla Capital Management LLC
Manager & Tenure Team Managed
Phone 800-451-2597
Website www.teklacap.com
Annual Report   Free Download
Total Net Assets (mil) as of 4/30/2013 $261.1
% Leveraged Assets as of 9/30/2012 --
Portfolio Turnover 86.00%
Mgmt Fees 1.074%
Expense Ratio 1.420%
Fund Objective
The Fund seeks long-term capital appreciation by investing primarily in securities of companies in the health services and medical technology (health care) industries ("Health care Companies").
Top Holdings (as of 12/31/2012)
Gilead Sciences Inc ORD 7.70%
Regeneron Pharmaceuticals Inc ORD 7.25%
Celgene Corp ORD 6.41%
Biogen Idec Inc ORD 4.47%
Alexion Pharmaceuticals Inc ORD 4.37%
Puma Biotechnology Inc ORD 2.89%
Perrigo Co ORD 2.86%
Mylan Inc ORD 2.78%
Merck & Co Inc ORD 2.45%
Hologic Inc ORD 2.27%
Top Sectors (as of 12/31/2012)
Health Care 82.85%
Non Classified Equity 11.33%
Consumer Services 1.81%
Technology 0.04%



























SySys Logo

Lipper Logo
Powered by a SySys® data & content management system.


© Thomson Reuters 2011. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
 
Data Definitions Asset Class Definitions Important Fund Performance & Ranking Disclaimer